Litcius/Paper detail

The microRNA-17 ~ 92 Family as a Key Regulator of Neurogenesis and Potential Regenerative Therapeutics of Neurological Disorders

Xiaohuan Xia, Yi Wang, Jialin Zheng

2020Stem Cell Reviews and Reports37 citationsDOIOpen Access PDF

Abstract

miR-17 ~ 92, an miRNA family containing three paralogous polycistronic clusters, was initially considered as an oncogene and was later demonstrated to trigger various physiological and pathological processes. Emerging evidence has implicated miR-17 ~ 92 family as a master regulator of neurogenesis. Through targeting numerous genes that affect cell cycle arrest, stemness deprivation, and lineage commitment, miR-17 ~ 92 family controls the proliferation and neuronal differentiation of neural stem/progenitor cells in both developmental and adult brains. Due to the essential roles of miR-17 ~ 92 family, its misexpression is widely associated with acute and chronic neurological disorders by attenuating neurogenesis and facilitating neuronal apoptosis. The promising neurogenic potential of miR-17 ~ 92 family also makes it a promising "medicine" to activate the endogenous and exogenous regenerative machinery, thus enhance tissue repair and function recovery after brain injury. In this review, we focus on the recent progress made toward understanding the involvement of miR-17 ~ 92 family in regulating both developmental and adult neurogenesis, and discuss the regenerative potential of miR-17 ~ 92 family in treating neurological disorders. Graphical abstract.

Topics & Concepts

NeurogenesisBiologyNeural stem cellmicroRNAStem cellProgenitor cellNeuroscienceRegulatorRegenerative medicineNeural developmentRegeneration (biology)Cell biologyGeneticsGeneMicroRNA in disease regulationNeurogenesis and neuroplasticity mechanismsCircular RNAs in diseases
The microRNA-17 ~ 92 Family as a Key Regulator of Neurogenesis and Potential Regenerative Therapeutics of Neurological Disorders | Litcius